A carregar...
Temporal analysis of pain responders and common adverse events: when do these first appear following treatment with pregabalin
BACKGROUND: Pregabalin is an α(2)δ ligand indicated in the USA for treatment of a number of chronic pain conditions, including diabetic peripheral neuropathy, postherpetic neuralgia, pain associated with spinal cord injury, and fibromyalgia. A greater understanding of when patients first respond to...
Na minha lista:
| Publicado no: | J Pain Res |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4494606/ https://ncbi.nlm.nih.gov/pubmed/26170712 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JPR.S82806 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|